Tus kws kho mob
upcoming-policies-effective-july3-2023.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1481 - 1490 ntawm 3685
Kev Cai Lij Choj thiab Kev Tswj Hwm
Blue Cross MN 2023 Annual Member Notice
Cov Txiaj Ntsig thiab Kev Duav Roos
Minnesota Senior Care Plus 2023 Spanish Member Handbook
Tus kws kho mob
QP34-23 Update for New to Market Medical Drugs: Tofersen
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Tus kws kho mob
QP35-23 Notice of Correction to Ambulance Mileage Reimbursement
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 12, 2023
Cov Txiaj Ntsig thiab Kev Duav Roos
BlueRide Parent or Guardian Ride Consent Form
Tus kws kho mob
P17-23 Inflation Reduction Act (IRA): Part B Rebatable Drugs and Part B Insulin Cap
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2023
Tus kws kho mob
Rapid to Intermediate Acting Insulin - Commercial
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Rapid to Intermediate Acting Insulin - Medicaid
Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Zoryve™ (roflumilast) - Commercial - Effective Date 02/01/2025
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2025